A mitochondria-targeted and viscosity-sensitive near-infrared fluorescent probe for visualization of fatty liver, inflammation and photodynamic cancer therapy
Li Fan,Qi Zan,Xiaodong Wang,Xue Yu,Shuohang Wang,Yuewei Zhang,Qianqian Yang,Wenjing Lu,Shaomin Shuang,Chuan Dong
DOI: https://doi.org/10.1016/j.cej.2022.137762
IF: 15.1
2022-07-04
Chemical Engineering Journal
Abstract:Elucidating the intrinsic relationship between disease and mitochondrial viscosity is great significance for understanding the diagnosis and treatment of fatty liver, inflammation and cancer. However, the development of a single mitochondrial viscosity fluorescent probe capable of visualizing multiple disease models and achieving photodynamic cancer therapy function is severely deficient and remains a great challenge. Herein we intelligently designed a mitochondria-targeted and viscosity-sensitive near-infrared (NIR) fluorescent probe POTA-OH, containing a p -hydroxydiphenylamino substituted oxanthracene moiety as the strong electron donor (D), a pyridinium cationic unit as the electron acceptor (A) and the mitochondria-targeted group. With increasing the viscosity level, POTA-OH displayed a significant "turn-on" fluorescence behavior at 720 nm, and an excellent linear relationship with viscosity from 0.89 cP to 945 cP. Meanwhile, POTA-OH could achieve effective reactive oxygen species production upon a 635 nm red laser irradiation. Using POTA-OH, we have demonstrated the visualization of fatty liver tissues, inflammation living mice, tumor living mice and even clinic cancer patient tissues samples via mitochondrial viscosity imaging. Furthermore, we revealed that POTA-OH has the potential of simultaneous PDT treatment in vitro and immediate evaluation of its therapeutic effect. Importantly, high-efficient PDT of POTA-OH has also successfully achieved for in vivo PDT antitumor, making it a promising integrated reagent for cancer diagnosis, treatment and even evaluation of PDT efficacy.
engineering, chemical, environmental